The Emerging Role of Novel Antihyperglycemic Agents in the Treatment of Heart Failure and Diabetes: A Focus on Cardiorenal Outcomes

Clinical Cardiology - United States
doi 10.1002/clc.23054
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

The Emerging Role of PDE5 Inhibition in Heart Failure

BMC Pharmacology
2007English

MicroRNA, Emerging Role as a Biomarker of Heart Failure

Circulation Journal
MedicineCardiovascular MedicineCardiology
2011English

Effects of Diabetes Compensation by Various Classes of Antihyperglycemic Agents on Endovascular Intervention Outcomes in Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2014English

Pharmacotherapy for Comorbidities in Chronic Heart Failure: A Focus on Hematinic Deficiencies, Diabetes Mellitus and Hyperkalemia

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2016English

Spotlight on Spironolactone Oral Suspension for the Treatment of Heart Failure: Focus on Patient Selection and Perspectives

Vascular Health and Risk Management
2019English

The Emerging Role of Epitranscriptomics in Cancer: Focus on Urological Tumors

Genes
Genetics
2018English

Positive inotroPic Agents for Treatment of Acute Heart Failure

The Bulletin of Contemporary Clinical Medicine
2013English

Insulin Treatment and Clinical Outcomes in Patients With Diabetes and Heart Failure With Preserved Ejection Fraction

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2019English

Treatment of Multiple Myeloma in Akita: Features and Outcomes in the Era of Novel Agents

Journal of clinical and experimental hematopathology : JCEH
Medicine
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy